Search

Search Constraints

You searched for: Author/Creator Margaritopoulos, G

Search Results

2. P56 What happens to patients with idiopathic pulmonary fibrosis who are not eligible for antifibrotic treatment due to current NICE guidelines. (12th November 2019)

3. P84 Advanced stage and aggressive cancers form a considerable proportion of lung malignancies in idiopathic pulmonary fibrosis and scleroderma-associated ILD. (December 2018)

4. S143 Serum CYFRA 21–1 as a prognostic marker in scleroderma-associated interstitial lung disease. (December 2018)

5. S57 Predictors of uptake of ambulatory oxygen on completion of the ambox trial, a study to assess effects of ambulatory oxygen on quality of life in patients with fibrotic interstitial lung disease. (15th November 2017)

6. S69 Verification of genetic associations with scleroderma associated interstitial lung disease. (12th November 2019)

7. S76 Pleuro-parenchymal fibroelastosis: traction bronchiectasis and extent of platythorax on computed tomography are determinants of disease progression and mortality. (December 2018)

8. S86 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis. (12th November 2019)